Birchview Capital, LP - Q4 2021 holdings

$155 Million is the total value of Birchview Capital, LP's 67 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 14.1% .

 Value Shares↓ Weighting
BMY SellBRISTOL-MYERS SQUIBB CO$47,767,000
+1.4%
766,106
-3.8%
30.80%
-3.9%
AXDX  ACCELERATE DIAGNOSTICS INC$11,732,000
-10.4%
2,252,3880.0%7.57%
-15.1%
AZYO BuyAZIYO BIOLOGICS INC$8,352,000
+2300.0%
1,417,923
+2735.8%
5.39%
+2172.6%
QDEL  QUIDEL CORP$8,057,000
-4.4%
59,6840.0%5.20%
-9.4%
NBIX BuyNEUROCRINE BIOSCIENCES INC$7,597,000
-1.2%
89,200
+11.2%
4.90%
-6.4%
FHTX  FOGHORN THERAPEUTICS INC$7,184,000
+64.2%
314,1430.0%4.63%
+55.6%
BDSX BuyBIODESIX INC$6,627,000
-27.0%
1,252,753
+13.4%
4.27%
-30.9%
ACAD  ACADIA PHARMACEUTICALS INC$4,654,000
+40.5%
199,4000.0%3.00%
+33.1%
UTHR  UNITED THERAPEUTICS CORP$3,889,000
+17.1%
18,0000.0%2.51%
+10.9%
BIIB  BIOGEN INC$3,023,000
-15.2%
12,6000.0%1.95%
-19.7%
ALBO  ALBIREO PHARMA INC$2,632,000
-25.4%
113,0000.0%1.70%
-29.3%
MASI  MASIMO CORP$2,342,000
+8.1%
8,0000.0%1.51%
+2.4%
ARNA  ARENA PHARMACEUTICALS INC$2,045,000
+56.1%
22,0000.0%1.32%
+48.0%
PRTA  PROTHENA CORP PLC$1,988,000
-30.7%
40,2470.0%1.28%
-34.3%
INBX NewINHIBRX INC$1,747,00040,000
+100.0%
1.13%
CLR  CONTINENTAL RESOURCES INC$1,728,000
-3.0%
38,6000.0%1.11%
-8.1%
BHVN BuyBIOHAVEN PHARMACEUTICAL HOLDING CO LTD$1,654,000
+19.1%
12,000
+20.0%
1.07%
+12.9%
KPTI  KARYOPHARM THERAPEUTICS INC$1,582,000
+10.5%
246,0000.0%1.02%
+4.7%
HROW  HARROW HEALTH INC$1,555,000
-5.0%
180,0000.0%1.00%
-9.9%
IMGN  IMMUNOGEN INC$1,410,000
+30.9%
190,0000.0%0.91%
+24.0%
ETRN  EQUITRANS MIDSTREAM CORPORATIO$1,376,000
+2.0%
133,0500.0%0.89%
-3.4%
NKTR BuyNEKTAR THERAPEUTICS$1,351,000
+4.5%
100,000
+38.9%
0.87%
-1.0%
PTGX  PROTAGONIST THERAPEUTICS INC$1,300,000
+93.2%
38,0000.0%0.84%
+83.0%
ARVN  ARVINAS INC$1,232,000
-0.1%
15,0000.0%0.79%
-5.4%
ALKS  ALKERMES PLC$1,163,000
-24.6%
50,0000.0%0.75%
-28.5%
OVV  OVINTIV INC$1,153,000
+2.6%
34,2000.0%0.74%
-2.7%
CYTK  CYTOKINETICS INC$1,140,000
+27.5%
25,0000.0%0.74%
+20.9%
GOSS BuyGOSSAMER BIO INC$1,131,000
+124.9%
100,000
+150.0%
0.73%
+113.2%
AMRN  AMARIN CORP PLCspons adr new$1,011,000
-33.9%
300,0000.0%0.65%
-37.4%
CORT  CORCEPT THERAPEUTICS INC$990,000
+0.6%
50,0000.0%0.64%
-4.8%
VNDA SellVANDA PHARMACEUTICALS INC$941,000
-31.4%
60,000
-25.0%
0.61%
-34.9%
BLUE  BLUEBIRD BIO INC$839,000
-47.7%
84,0000.0%0.54%
-50.5%
PGNY  PROGYNY INC$755,000
-10.1%
15,0000.0%0.49%
-14.9%
CCXI SellCHEMOCENTRYX INC$728,000
+70.1%
20,000
-20.0%
0.47%
+61.2%
New2SEVENTY BIO INC$718,00027,999
+100.0%
0.46%
CGEM  CULLINAN ONCOLOGY INC$696,000
-31.6%
45,1140.0%0.45%
-35.2%
PXD  PIONEER NATURAL RESOURCES CO$691,000
+9.2%
3,8000.0%0.45%
+3.5%
ZNTL  ZENTALIS PHARMACEUTICALS INC$672,000
+26.1%
8,0000.0%0.43%
+19.3%
AVEO BuyAVEO PHARMACEUTICALS INC$657,000
+166.0%
140,000
+250.0%
0.42%
+152.4%
NARI  INARI MEDICAL INC$639,000
+12.5%
7,0000.0%0.41%
+6.5%
APLS  APELLIS PHARMACEUTICALS INC$567,000
+43.2%
12,0000.0%0.37%
+36.1%
KALV  KALVISTA PHARMACEUTICALS INC$529,000
-24.2%
40,0000.0%0.34%
-28.2%
CFRX  CONTRAFECT CORP$526,000
-35.1%
200,0000.0%0.34%
-38.5%
NewVENTYX BIOSCIENCES INC$497,00025,000
+100.0%
0.32%
XNCR  XENCOR INC$493,000
+22.6%
12,3000.0%0.32%
+16.1%
IRTC  IRHYTHM TECHNOLOGIES INC$471,000
+101.3%
4,0000.0%0.30%
+91.2%
FOLD  AMICUS THERAPEUTICS INC$439,000
+20.9%
38,0000.0%0.28%
+14.6%
GTHX  G1 THERAPEUTICS INC$408,000
-24.0%
40,0000.0%0.26%
-27.9%
TPTX  TURNING POINT THERAPEUTICS INC$382,000
-28.1%
8,0000.0%0.25%
-31.9%
SLNO  SOLENO THERAPEUTICS INC$360,000
-55.6%
876,8990.0%0.23%
-58.0%
STOK  STOKE THERAPEUTICS INC$360,000
-5.8%
15,0000.0%0.23%
-10.8%
KNSA  KINIKSA PHARMACEUTICALS LTD$353,000
+3.2%
30,0000.0%0.23%
-2.1%
SILK NewSILK ROAD MEDICAL INC$341,0008,000
+100.0%
0.22%
IFRX  INFLARX NV$333,000
+84.0%
70,0000.0%0.22%
+74.8%
TGTX  TG THERAPEUTICS INC$285,000
-42.9%
15,0000.0%0.18%
-45.9%
BCRX  BIOCRYST PHARMACEUTICALS INC$277,000
-3.5%
20,0000.0%0.18%
-8.2%
ISEE  IVERIC BIO INC$251,000
+2.9%
15,0000.0%0.16%
-2.4%
PFE NewPFIZER INC$236,0004,000
+100.0%
0.15%
LSF BuyLAIRD SUPERFOOD INC$235,000
-12.0%
18,000
+28.6%
0.15%
-16.5%
AKBA  AKEBIA THERAPEUTICS INC$226,000
-21.5%
100,0000.0%0.15%
-25.5%
AWH  ASPIRA WOMENS HEALTH INC$182,000
-45.7%
103,1040.0%0.12%
-48.7%
ANGN  ANGION BIOMEDICA CORP$158,000
-70.2%
54,3920.0%0.10%
-71.7%
SIEN  SIENTRA INC$147,000
-35.8%
40,0000.0%0.10%
-39.1%
NewDOCGO INC$94,00010,000
+100.0%
0.06%
YTEN SellYIELD10 BIOSCIENCE INC$92,000
-18.6%
18,750
-0.2%
0.06%
-23.4%
CNCE  CONCERT PHARMACEUTICALS INC$63,000
-3.1%
20,0000.0%0.04%
-6.8%
TXMD SellTHERAPEUTICSMD INC$18,000
-75.7%
50,000
-50.0%
0.01%
-76.0%
ARQT ExitARCUTIS BIOTHERAPEUTICS INC$0-9,000
-100.0%
-0.15%
PROG ExitPROGENITY INC$0-270,000
-100.0%
-0.28%
XLRN ExitACCELERON PHARMA INC$0-10,672
-100.0%
-1.25%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ACCELERATE DIAGNOSTICS INC36Q3 202334.6%
QUIDELORTHO CORP36Q3 20238.6%
MASIMO CORP36Q3 20232.2%
PIONEER NATURAL RESOURCES CO (PXD)36Q3 20230.7%
XENCOR INC35Q3 20230.4%
NEUROCRINE BIOSCIENCES INC33Q3 20237.4%
CORCEPT THERAPEUTICS INC32Q3 20231.2%
BIOGEN INC31Q2 20223.1%
CONTRAFECT CORP30Q3 20221.6%
YIELD10 BIOSCIENCE INC26Q3 20230.6%

View Birchview Capital, LP's complete holdings history.

Latest significant ownerships (13-D/G)
Birchview Capital, LP Q4 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
SOLENO THERAPEUTICS INCMarch 19, 2019742,6352.3%
YIELD10 BIOSCIENCE, INC.December 29, 2017186,0792.2%
HANSEN MEDICAL INCFebruary 16, 2016? ?
METABOLIX, INC.June 23, 2015749,6962.8%

View Birchview Capital, LP's complete significant-ownership history.

Latest filings
TypeFiled
3/A2024-02-20
4/A2024-02-20
SC 13G/A2024-02-20
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-08
13F-HR2023-05-12
SC 13G/A2023-04-07
42023-03-27
32023-02-13

View Birchview Capital, LP's complete filings history.

Compare quarters

Export Birchview Capital, LP's holdings